Low metabolite biomarkers linked to chronic pruritus of unknown origin
New findings show that patients with chronic pruritus of unknown origin (CPUO) have lower-than-normal levels of some metabolite...
top of page
it's where dermatology lives
John Evans
Jun 142 min read
Abrocitinib improves chronic itching conditions
New research shows that the Janus kinase (JAK) inhibitor abrocitinib, approved in Canada for the treatment of moderate-to-severe atopic...
Allan Ryan
May 62 min read
Neuropeptide in blood may lead to targeted treatment for chronic itch
A new study has identified what may be the first biomarker for chronic itch. Published in Drugs in Dermatology, researchers from the...
John Evans
Oct 13, 20232 min read
Sleep disturbance common among patients with skin disease
More than two-fifths (42%) of patients with skin disease experience sleep disturbances, according to an international study presented at...
Allan Ryan
Jun 27, 20222 min read
Protein in sensory nerves acts as sensor for mechanical itch
The protein PIEZO1 in sensory nerves appears to be a key detector of mechanical itch—as opposed to chemically-induced itch caused by...
Allan Ryan
Jun 6, 20221 min read
Herbal remedies investigated in chronic pruritus
While there is only limited evidence that herbal remedies have a clinical effect on chronic pruritus, it does appear that turmeric,...
Allan Ryan
Jan 31, 20221 min read
AD symptoms get worse during premenstrual period
A research letter published in the Journal of the American Academy of Dermatology has outlined the degree to which symptoms of atopic...
Jeremy Visser
Jun 9, 20211 min read
VIDEO: Dupilumab treatment for atopic dermatitis associated with increase ocular disease prevalence
New research has linked dupilumab treatment in atopic dermatitis (AD) patients with an increased prevalence of ocular disease.
Featured Posts
bottom of page